Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ADVIA Centaur Anti-Thyroglobulin II (aTgII)

K-Number: K250816 · 2025-12-04

Decision Date2025-12-04
Product CodeJNL
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

ADVIA Centaur Anti-Thyroglobulin II (aTgII) is a medical device manufactured by Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2025-12-04 under approval number K250816. The device is classified under product code JNL. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ADVIA Centaur Anti-Thyroglobulin II (aTgII)?

ADVIA Centaur Anti-Thyroglobulin II (aTgII) is a medical device that received FDA 510(k) clearance on 2025-12-04. It is manufactured by Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K250816.

When was ADVIA Centaur Anti-Thyroglobulin II (aTgII) approved by the FDA?

ADVIA Centaur Anti-Thyroglobulin II (aTgII) received FDA 510(k) clearance on 2025-12-04, under approval number K250816.

What company makes ADVIA Centaur Anti-Thyroglobulin II (aTgII)?

ADVIA Centaur Anti-Thyroglobulin II (aTgII) is manufactured by Siemens Healthcare Diagnostics, Inc..

What is the FDA product code for ADVIA Centaur Anti-Thyroglobulin II (aTgII)?

The FDA product code for ADVIA Centaur Anti-Thyroglobulin II (aTgII) is JNL.

Other Devices by Siemens Healthcare Diagnostics, Inc.

View all 71 devices →

Related Devices (Code: JNL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.